Endospan, a leader in endovascular solutions for the Aortic Arch, has announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational Device Exemption (IDE) clinical study, which evaluates the safety and efficacy of the NEXUS® Aortic Arch…
At the 23rd Human Proteome Organization World Congress, Bruker Corporation (Nasdaq: BRKR) announced significant advancements in deep, unbiased, and high-sensitivity 4D-Proteomics. These developments enable robust, high-fidelity, large-scale studies while minimizing the inherent cross-talk issues associated with affinity high-plex technologies. A.…
NUCLIDIUM has announced the successful imaging of its first patient in a Phase 1 clinical trial for its radiotracer candidate, aimed at providing a safe and accurate diagnostic tool for prostate cancer. The radiotracer, 61Cu-NuriPro™ (61Cu-NODAGA-PSMA I&T), targets Prostate Specific…
Galderma has announced new Phase III data from the READY-4 clinical trial, showcasing the long-term safety and efficacy of RelabotulinumtoxinA (Relfydess™) for treating frown lines and crow’s feet after repeated injections. The study met its primary and secondary endpoints, revealing…
Blue Lake Biotechnology, Inc., a clinical-stage company focused on intranasal vaccines using parainfluenza virus 5 (PIV5) vectors, and its affiliate CyanVac LLC, announced the presentation of positive interim pediatric clinical data for BLB201, their vaccine candidate targeting respiratory syncytial virus…
Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative neuropsychiatric medicines, has successfully closed an oversubscribed $225 million Series B financing round. The round was led by General Atlantic, a prominent global growth investor, with participation from T. Rowe…
Agilent Technologies Inc. (NYSE: A) has unveiled its next-generation Agilent InfinityLab LC Series, featuring the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all available in biocompatible versions. These systems are the first…
Definitive Healthcare (Nasdaq: DH) has launched Monocl Conferences, a new solution aimed at improving conference planning and participation for life science organizations. This platform provides medical affairs, marketing, and conference planning teams with detailed, contextualized data on key conferences, helping…
The World Health Organization reports that breast cancer was the most commonly diagnosed cancer among women in 157 out of 185 countries in 2022. That year, 2.3 million women were diagnosed with breast cancer, and tragically, 666,000 lost their lives…
Select Medical Corporation and SSM Health have announced a joint venture to establish the SSM Health Rehabilitation Hospital – Oklahoma City, a 50-bed inpatient rehabilitation facility located at 700 NW 7th Street. This hospital will incorporate SSM Health’s existing 12-bed…
QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative in vitro diagnostic technologies for point-of-care settings, clinical labs, and transfusion medicine, will report its financial results for the third quarter of 2024, ending September 29, 2024. The results will be…
The medical team at Al-Mouwasat Hospital in Al-Khobar has successfully performed a series of surgeries to remove cancerous kidneys, under the guidance of Dr. Abdulrahman Abdulkarim Al-Muhrej, a Consultant in Urological Oncology and Robotic Surgery. Utilizing a robotic system, the…